Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

Advanced Medical Technology Association (AdvaMed)

After 2-Year Hiatus, 2.3 Percent Medical Device Tax Could Be Reinstated on January 1; Industry Launches Campaign

Washington, DC, August 15, 2017 — Bob Salsberg reports in The Washington Post that the industry that makes medical devices from artificial hips to miniature pumps for IV drips is looking for a fallback plan to permanently repeal a widely reviled sales tax that almost met its end in Republicans’ health care legislation.

The 2.3 percent medical device excise tax — one of several taxes and fees in the Affordable Care Act that pay for expanded insurance coverage — has been the subject of ferocious lobbying by manufacturers seeking its permanent death.

Yet for now it’s on track to be reinstated on Jan. 1 after a two-year hiatus, leaving industry leaders worried it will hurt employment and stifle development of innovative, even lifesaving products. Continue reading

Medical Device Group Launches Ad Campaign to Repeal Obamacare’s 2.3 Percent Excise Tax

Washington, DC, August 10, 2017 — Peter Sullivan reports in The Hill that the Advanced Medical Technology Association (AdvaMed) is launching a new advertising campaign to push lawmakers to repeal Obamacare’s tax on medical devices.

AdvaMed will be running the digital and social media ads in 15 states this month, pushing lawmakers to repeal the medical device tax when they return from recess in September.  Continue reading

AdvaMed’s MedTech Conference Honors Green Sun Medical as 2016 MedTech Innovator Winner

advamed-logo-croppedWashington, DC, November 8, 2016 — AdvaMed 2016: The MedTech Conference, the leading event for medical technology professionals in North America, and MedTech Innovator named Green Sun Medical the first place winner of the global competition and awarded the company a $200,000 cash prize.

The honor was announced during the Advanced Medical Technology Association’s (AdvaMed) 2016 MedTech Conference, which was held October 17-19 in Minneapolis, MN.

Held in partnership with AdvaMed Accel, MedTech Innovator is the medtech industry’s global competition and virtual accelerator that identifies and accelerates the development of transformative innovations. Continue reading

AdvaMed Recommits to Fostering Early-State Innovation; New Report Highlights Challenges to Medtech Entrepreneurship

advamed-logo-croppedWashington, DC, October 25, 2016 — The Advanced Medical Technology Association (AdvaMed) on October 17 affirmed its commitment to advancing a comprehensive set of policy objectives to invigorate the innovation ecosystem for early-stage device and diagnostics companies.

A new report — “A Future at Risk:  Economic Performance, Entrepreneurship, and Venture Capital in the U.S, Medical Technology Sector” — released at the association’s annual meeting, outlines significant warning signs that, if left unaddressed, could hamper long-term growth and entrepreneurship.

Some key signals identified in the report, based on a number of independent sources on medtech industry trends, include: Continue reading

U.S. Senate Panel Approves Legislation to Speed Approval of Medical Devices; AdvaMed Commends HELP Committee

Capitol Rotunda flagWashington, DC, March 10, 2016 ― Thomas M. Burton reports in The Wall Street Journal that a United States Senate committee Wednesday approved a slate of bills that would relax requirements for approval of medical devices by the Food and Drug Administration (FDA), part of a larger effort aimed at speeding up the regulatory process and boosting medical research.

Most of the measures were approved with bipartisan support, but there are indications of discord on the package.  Some patient-safety advocates said the legislation would weaken the FDA’s ability to ensure the dependability and safety of medical devices.

The bills approved Wednesday are expected to become part of comprehensive medical legislation that also could provide a big budgetary boost to medical research at the National Institutes of Health.  New money for the NIH is a priority of Democrats and the Obama administration. Continue reading

AdvaMed Names Scott Whitaker CEO and President

Scott Whitaker AdvaMed CEOWashington, DC, February 19, 2016 ― The Board of Directors of the Advanced Medical Technology Association (AdvaMed) announced yesterday that Scott Whitaker will be its next president and chief executive officer effective April 4, 2016.

Whitaker joins AdvaMed, the world’s leading association for medical technology companies, having served most recently as chief operating officer of the Biotechnology Innovation Organization (BIO).

“We are very pleased that Scott has agreed to lead AdvaMed at a time of unprecedented change in health care,” said AdvaMed Board Chairman Vincent A. Forlenza, chairman, CEO and president of BD. Continue reading